De novo designed proteins that target the transmembrane domain of G-protein-coupled receptors, created using iterative structural predictions, are able to act as agonist-positive, negative or biased allosteric modulators of downstream activity.
- Shizhuo Cheng
- Jia Guo
- Yan Zhang
